IE
IMNN icon

Israel Englander’s Imunon IMNN Stock Holding History

Israel Englander’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-214
Closed -$23K – 7158
2021
Q4 		$23K Buy
+214
New +$33.3K ﹤0.01% 6592
2021
Q3 		– Sell
-916
Closed -$228K – 7000
2021
Q2 		$228K Buy
+916
New +$217K ﹤0.01% 5930
2020
Q3 		– Sell
-103
Closed -$75K – 4620
2020
Q2 		$75K Buy
+103
New +$44.7K ﹤0.01% 4013
2018
Q2 		– Sell
-59
Closed -$26K – 3957
2018
Q1 		$26K Buy
+59
New +$28.4K ﹤0.01% 3561
2014
Q3 		– Sell
-12
Closed -$113K – 3829
2014
Q2 		$113K Buy
12
+6
+100% +$53.6K ﹤0.01% 3241
2014
Q1 		$52K Buy
+6
New +$62.5K ﹤0.01% 3353

Other funds holding IMNN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Israel Englander's IMNN Position: Q1 2022 in Review

Israel Englander sold out of Imunon (IMNN) in Q1 2022, closing a stake of 214 shares — an estimated $23K sold.

Israel Englander first reported a position in IMNN in Q1 2014 and held it in 6 quarters. The position peaked at $228K in Q2 2021. 23 funds tracked by Wall St. Rank hold IMNN as of Q1 2022.

  • Israel Englander reported no remaining Imunon position as of Q1 2022 after selling out during the quarter.
  • Israel Englander sold 214 Imunon shares in Q1 2022, an estimated $23K.
  • Israel Englander first reported a position in Imunon in Q1 2014 and held it in 6 quarters.
  • Israel Englander's Imunon position peaked at $228K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.